‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot

Novavax was expected to finally nab full approval of its COVID-19 vaccine on 1 April. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Vaccines